EUVIMEDEUVIMED entdecken
Crossref

Drug delivery as a sustainable avenue to future therapies

Gregor Fuhrmann

Journal of Controlled Release · 2023-02 · 354 · 746-754

DOI: 10.1016/j.jconrel.2023.01.045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2023-02. Verfasst von Gregor Fuhrmann. Beteiligte Einrichtung: Friedrich-Alexander-Universität Erlangen-Nürnberg, Department of Biology, Pharmaceutical Biology, Staudtstr. 5, 91058 Erlangen, Germany. Electronic a…. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 70 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Climate change and the need for sustainable, technological developments are the greatest challenges facing humanity in the coming decades. To address these issues, in 2015 the United Nations have established 17 Sustainable Development Goals. Anthropogenic climate change will not only affect everyone personally in the coming years, it will also reinforce the need to become more sustainable within drug delivery research. In 2021, I was appointed professor for pharmaceutical biology at the Friedrich-Alexander-University Erlangen-Nürnberg. Our research is at the interface between developing biogenic therapies and understanding of bacterial infections. In this contribution to the Orations - New Horizons of the Journal of Controlled Release, I would like to underline the need for future sustainable approaches in our research area, by highlighting selected examples from the fields of infection research, natural product characterisation and extracellular vesicles. My aim is to put into perspective current issues for these research topics, but also encourage our current student-training framework to contribute to education for sustainable development. This contribution is a personal statement to increase the overall awareness for sustainability challenges in drug delivery and beyond.

Schlagwörter

Stichwörter der Autor:innen

Academic publishingEducation for sustainable developmentExtracellular vesiclesInfection researchNatural productsSustainable development goalsSustainable pharmacy

Autor:innen und Institutionen

  • Friedrich-Alexander-Universität Erlangen-Nürnberg, Department of Biology, Pharmaceutical Biology, Staudtstr. 5, 91058 Erlangen, Germany. Electronic address: gregor.fuhrmann@fau.de.

Zitieren

APA

Fuhrmann, G. (2023). Drug delivery as a sustainable avenue to future therapies. Journal of Controlled Release, 354, 746-754. https://doi.org/10.1016/j.jconrel.2023.01.045

Vancouver

Fuhrmann G. Drug delivery as a sustainable avenue to future therapies. Journal of Controlled Release. 2023;354:746-754. doi:10.1016/j.jconrel.2023.01.045

BibTeX
@article{Fuhrmann2023,
  author = {Fuhrmann, Gregor},
  title = {Drug delivery as a sustainable avenue to future therapies},
  journal = {Journal of Controlled Release},
  year = {2023},
  volume = {354},
  pages = {746--754},
  doi = {10.1016/j.jconrel.2023.01.045}
}
Kostenlos starten →